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Abstract
Background: Articular cartilage displays a poor repair capacity. The aim of cell-based therapies for cartilage defects is to
repair damaged joint surfaces with a functional replacement tissue. Currently, chondrocytes removed from a healthy region
of the cartilage are used but they are unable to retain their phenotype in expanded culture. The resulting repair tissue is
fibrocartilaginous rather than hyaline, potentially compromising long-term repair. Mesenchymal stem cells, particularly
bone marrow stromal cells (BMSC), are of interest for cartilage repair due to their inherent replicative potential. However,
chondrocyte differentiated BMSCs display an endochondral phenotype, that is, can terminally differentiate and form a
calcified matrix, leading to failure in long-term defect repair. Here, we investigate the isolation and characterisation of a
human cartilage progenitor population that is resident within permanent adult articular cartilage.
Methods and Findings: Human articular cartilage samples were digested and clonal populations isolated using a
differential adhesion assay to fibronectin. Clonal cell lines were expanded in growth media to high population doublings
and karyotype analysis performed. We present data to show that this cell population demonstrates a restricted differential
potential during chondrogenic induction in a 3D pellet culture system. Furthermore, evidence of high telomerase activity
and maintenance of telomere length, characteristic of a mesenchymal stem cell population, were observed in this clonal cell
population. Lastly, as proof of principle, we carried out a pilot repair study in a goat in vivo model demonstrating the ability
of goat cartilage progenitors to form a cartilage-like repair tissue in a chondral defect.
Conclusions: In conclusion, we propose that we have identified and characterised a novel cartilage progenitor population
resident in human articular cartilage which will greatly benefit future cell-based cartilage repair therapies due to its ability to
maintain chondrogenicity upon extensive expansion unlike full-depth chondrocytes that lose this ability at only seven
population doublings.
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Introduction
Articular cartilage displays a poor repair capacity. Consequently,
the aim of cartilage cell therapy procedures is to repair damaged
joint surfaces with a functional replacement tissue. As an avascular
tissue, cartilage comprises a single cell type – the chondrocyte,
which is organised into three distinct layers – the surface, mid and
deep zones [1]. Chondrocytes required for cell-based therapies are
isolated and expanded in vitro to generate sufficient numbers of cells
for surgical procedures. However, extensive expansion results in the
progressive dedifferentiation of the chondrocytes. In culture, human
chondrocytes show an inability to retain a chondrogenic potential
past 7 population doublings, even after cultivation in a chondro-
genically permissive environment [2,3,4]. In order to combat this
problem of dedifferentiation, research has focussed on the use of
growth factors and 3D culture systems as a way of maintaining the
chondrogenic potential of these cells [5,6,7,8]. Although these
modifications, to some extent, have proved successful they would be
unsuitable as a method of expanding cells for use in cell-based repair
therapies and, as such, monolayer culture is a limiting factor for
chondrocyte efficacy. Additionally, when chondrocytes are used in
cell-based tissue engineering, the resulting repair tissue is unpre-
dictable and often fibrocartilagenous. It is argued that this
fibrocartilage is biochemically and biomechanically inferior to
native cartilage thus compromising long-term repair of the cartilage
defect [9,10,11].
The loss of the chondrogenic phenotype during monolayer
culture means that the size of defect that can be treated is limited
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since only a defined amount of cartilage can be harvested from the
joint periphery. One way to overcome this cell source limitation
would be to use an alternative cell type that maintains its inherent
proliferative capacity, such as a mesenchymal stem cell (MSC)
population [12]. Recently, studies have demonstrated that cells
obtained from a range of adult tissues eg. adipose, epidermal,
dental pulp and bone marrow exhibit mesenchymal/progenitor
type properties; they can differentiate into multiple lineages and
express putative stem cell markers and as such, could be used for
cell-based repair therapies [13,14,15,16,17,18,19,20]. In particu-
lar, studies have highlighted that MSCs obtained from bone
marrow could be used in cartilage repair procedures as bone
marrow stromal cells (BMSC) can be directed towards the
chondrogenic lineage [21]. However, articular cartilage is a
permanent cartilage and the phenotype generated by BMSCs is
endochondral, which will terminally differentiate, an unfavourable
outcome if one wants to repair permanent articular cartilage. At
present, the type of cartilage generated by stem cells from other
tissue types is poorly characterised [22,23].
Instead of utilising MSCs from different tissue sources for
cartilage repair strategies, it would be logical to use cells from the
same tissue as these cells may possess the developmental repertoire
of the native tissue, impacting on the morphogenesis of the repair
tissue in a beneficial way. Previously, research has hypothesised
that foetal and immature articular cartilage develops apposition-
ally – that is from the surface to the deep zone [24]. In support of
these data, the identification of a chondroprogenitor population in
the surface of bovine articular cartilage has been described and
this has opened up the possibility that human cartilage could also
contain a cartilage progenitor population [25,26]. Identification
and characterisation of this cartilage progenitor population in
human tissue has begun in earnest. Many studies relying on the
use of several putative stem cell markers to determine a method by
which these cells can be isolated from a full-depth articular
chondrocyte population [27,28,29]. As of yet, however, no suitable
single marker has been established and it is becoming increasingly
evident that a high percentage of mature chondrocytes also
express these markers thus confounding previous studies, especially
in the absence of clonal analysis [30,31]. As cell surface marker
expression can alter in monolayer culture, then it is important that
other classical stem cell characteristics are relied on to determine
whether a true cartilage progenitor population has been isolated
[31,32].
This study describes the isolation of a distinct cartilage
progenitor population resident in normal human cartilage of
varying ages. The methodologies employed result in the
generation of large numbers of cells from a single cell. Upon
characterisation of this cell population derived from a single cell,
we demonstrate its progenitor-like properties. As such, we propose
that the human cartilage progenitor population characterised in
this study is a suitable candidate for advancing cell-based tissue
repair therapies for cartilage defects.
Materials and Methods
Ethics Statement
Cartilage tissue samples were obtained from patients who
underwent knee surgery. South East Wales NHS Research Ethics
Committee specifically approved this study and institutional safety
and ethical guidelines were followed. Written informed consent
was obtained from each patient, and extensive precautions were
taken to preserve the privacy of the participants donating tissue.
All caprine in vivo studies were approved by the Office for Food
Safety and Animal Health Graubunden, permitting the project to
take place under the title PROCART. Experiments were carried
out under the strict guidelines of the AO Research Institute,
Switzerland.
Cell isolation & fibronectin adhesion assay
Full-depth normal human articular cartilage samples from
femoral chondyles (n = 9; mean age 30.0 yrs, range 10–57) were
obtained. Chondrocytes were isolated by sequential pronase
(70 U ml21, 1 hour at 37uC) and collagenase (300 U ml21,
3 hours at 37uC) digest. Isolated cells were plated down as a
full-depth chondrocyte population (total cell mass from surface,
mid and deep zones) or subjected to a fibronectin adhesion assay
as described [33]. Briefly, six well plates were coated with
10 mg ml21 fibronectin (FN; Sigma, UK) in 0.1 M phosphate
buffered saline (PBS, pH7.4) containing 1 mM MgCl and 1 mM
CaCl2 (PBS+) overnight at 4uC. Control dishes were treated with
PBS+ containing 0.1% BSA overnight at 4uC. Isolated full-depth
chondrocytes (4000 cells ml21) were seeded onto the coated plates
for 20 mins at 37uC in Dulbeccos Modified Eagle Medium
(DMEM). In all experiments, a minimum of 3 fibronectin and 3
BSA coated dishes were used. After 20 mins, media and non-
adherent cells were removed. Fresh DMEM containing Penicillin
10000 mg ml21/Streptomycin 10000 U ml21, 0.1 mM ascorbic
acid, 0.5 mg ml21 L-glucose, 100 mM HEPES, 1 mM sodium
pyruvate, 2 mM L-glutamine and 10% fetal bovine serum (FBS)
(DMEM+) were added to the remaining adherent cells. Within
18 hours of plating, the number of cells adhered was counted.
Twelve days after plating, colonies (defined as a cluster of more
than 32 cells, as this represents a population of cells derived from
more than 5 population doublings of a single cell, thereby
discounting a transit amplifying cell cohort) were counted and
colony forming efficiency calculated [33]. Colonies were selected
and isolated using sterile cloning rings (Sigma, UK). Colonies were
expanded in DMEM+ plus 1 ng ml21 Transforming Growth
Factor – b2 (TGF-b2; PeproTech, UK) and 5 ng ml21 Fibroblast
Growth Factor-2 (FGF-2; PeproTech, UK). At each passage, the
number of cells obtained and re-plated was recorded. From these
data, population doublings from 4 specimens, with at least 3 clones
from each specimen, were calculated using the equation: n = [log
(final cell count) - log (number of cells initially plated)]/0.301
[34].a
Flow cytometry
One million full-depth chondrocytes (passage 5) were washed in
PBS and incubated for 1 hour at 4uC with conjugated antibodies
to CD105-FITC (Ancell), CD166-RPE (Ancell), CD44-FITC
(Pharminogen), CD29-FITC (Chemicon) or CD49e-PE (Chemi-
con) at a concentration of 10 mg ml21. Cells were centrifuged at
20006g, supernatants removed and cells washed three times in
PBS. Finally, labelled cells were re-suspended in 1 ml PBS and
subjected to single channel Fluorescently Activated Cell Sorting
(FACS) analysis. The appropriate IgG controls were run in
parallel. A minimum of three clones were analysed for each
antibody.
Immunocytochemistry
Monolayer cultures of full-depth chondrocytes and cartilage
progenitors were fixed and subjected to immunofluorescence for
antibodies to anti-human Notch 1 (Developmental Studies
Hybridoma Bank, USA), anti-human CD90 (BD Pharminogen,
USA), anti-human STRO-1 (R&D Systems, USA), anti-rabbit
Jagged 1 (Santa Cruz Biotech, USA) and anti-goat Delta 1 (Santa
Cruz Biotech). Monolayer cultures subjected to chondrogenic
induction were analysed for anti-mouse Sox9 (Abcam, UK),
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aggrecan-IGD; 6B4+ and 2B6 (both kind gifts of Professor Bruce
Caterson, Cardiff University), collagen type I (10 mg ml21;
Abcam) and collagen type II (DSHB). Full protocols can be found
in supporting information (Text S1). Pellets from a minimum of 3
different clonal cell lines were labelled for each antibody.
Cell differentiation assays
Expanded clonal cell lines and full-depth chondrocytes were
trypsinised and aliquots of 0.56106 cells per 1 ml of media were
centrifuged at 20006g for 5 mins in 1.5 ml Eppendorf tubes to
form spherical pellets. For chondrogenic differentiation, pellets
were suspended in DMEM supplemented with ITS (10 mg ml21
insulin, 5.5 mg ml21 transferrin, 5 ng ml21 selenium; GIBCO,
UK), 100 mg ml21 Gentamicin, 50 mg ml21 L-ascorbic acid,
1 mg ml21 L-glucose, 2 mM L-glutamine, 10 mM HEPES, 1027
M dexamethasone, 2% FBS and 10 ng ml21 TGF-b2. For
osteogenic differentiation pellets were suspended in DMEM,
10% FBS, 10 mM b-glycerophosphate, 10 nM dexamethasone
and 0.1 mM L-ascorbic-acid-2-phosphate. Pellets were cultured
for 21 days with a medium change every other day.
Monolayer cultures of cartilage progenitor cell lines and full-
depth chondrocytes were also established and cultured in
chondrogenic differentiation media or adipogenic differentiation
was induced using cycles of treatment with adipogenic induction
media or adipogenic maintenance media as previously described
[35]. Cell monolayers cultured in adipogenic medium were fixed
in 10% NBFS for 10 mins. For lipid detection, a stock solution
(0.5% Oil Red O in 100% isopropanol) was diluted at a ratio of
4:6 with dH2O and the cells incubated for 1 hour.
Preparation of pellets for analysis
At 21 days, cell pellets were fixed in 4% para-formaldehyde,
embedded in paraffin and cross-sectioned at 8 mm or following
fixation in 10% neutral buffered formalin, the pellets were fully
dehydrated and processed into Technovit 9100 NewH (TAAB
Laboratories, UK) using the chemical catalytic method fully
described by Yang et al, [36] with fully destabilised resin at all steps
[37]. The pellets embedded in Technovit 9100 NewH resin
sections were cut using glass knives to a thickness of 1 mm.
Pellet analysis
Wax embedded pellet sections were dewaxed in xylene and
hydrated in a decreasing graded alcohol series. Technovit
9100HNew embedded pellets were de-acrylated in 2-methoxyethyl
acetate (Sigma, Dortset, UK) for 3–4 hours followed by rehydration
through xylene, and a series of graded ethanol. Resin autofluores-
cence was quenched by immersing tissue sections in 1% sodium
borohydride and equilibrated in PBS as previously described [37].
Pellets sections were then subjected to standard histological
protocols for safranin O and toluidine blue staining for proteoglycan
detection. Alizarin red and von Kossa staining were used to
determine the extent of mineralisation and picro-sirius red staining
was performed to demonstrate collagen fibril synthesis within the
pellet matrix. Immunofluorescent analysis for cartilage (Collagen
type I & II, 2B6, aggrecan) and osteogenic (Collagen type X,
alkaline phosphatase) components was performed, as described
above and more fully in supporting information (Text S1).
PCR analysis
At 21 days, cell pellets cultured in osteogenic differentiation
media were placed into buffer RLT (Qiagen, UK). Cell
monolayers from adipogenic cultures were lysed from the tissue
plastic using buffer RLT (Qiagen, UK). RNA was extracted from
pellet and monolayer cells using a kit (RNAEasy, Qiagen, UK)
with a DNAseI incubation step. RNA was quantified using a
Nanodrop 2000c spectrophotometer and 100 ng of each sample
was used for reverse transcription. Polymerase chain reactions
were performed using the following primer combinations for lipo-
protein lipase forward 59CTGAAGACACAGCTGAGGAC39,
reverse 59CTGGTGAATGTGTGTAAGAC39, osteonectin for-
ward 59TCCACAGTACCGGATTCTCTCT39, reverse 59TCT-
ATGTTAGCACCTTGTCTCCAG39, 18S rRNA forward 59G-
ATGGGCGGCGGAAAATAG39, reverse 59GCGTGGATTC-
TGCATAATGGT39. PCR reactions were amplified using the
following conditions 95uC 2 min-1 cycle, 95uC 30 sec, 53uC
30 sec, 72uC 30 sec-35 cycles, 72uC 5 min-1cycle.
Cytogenetic analysis
Cytogenetic investigations were undertaken on 1 clonal cell line
from 1 specimen (10 year-old female; PD=31.3) and 2 clonal cell
lines from a different specimen (54 year-old female; PD=23.6 &
28.5). Cultures were selected for harvest when cell growth was
almost confluent. Chromosome preparations were obtained using
a modification of conventional techniques explained in detail in
supporting information (Text S2) [38]. The karyotype was
determined by microscopic examination after modification of the
Giemsa staining and banding analysis [39,40].
Telomere length analysis
Two full-depth chondrocyte populations (1 at PD10 and 1 at
PD12) and 3 clonal cell lines (1 at PD 29, the second at PD26 and
PD39 and the third at PD29 and PD38), were washed in sterile
PBS, pelleted at 1.06106 cells and frozen in liquid nitrogen for
telomere length analysis. DNA extractions and single length
telomere analysis (STELA) reactions at the 17p and XpYp
telomeres were carried out as described previously and in full in
supporting information (Text S3) [41]. Corresponding telomerase
activity using real time quantitative repeat amplification procedure
(RTQ-TRAP) was carried out for the corresponding full-depth
chondrocyte and clonal cell lines, described in full in supporting
information (Text S4).
In ovo injections and tissue processing
Cell engraftments: Clonal cells were expanded, harvested, and
aliquots of between 16104–16105 cells re-suspended in media and
immediately injected into the limb bud of 3-day-old (st23) [42]
chick embryos which had previously been windowed. Eggs were
resealed with adhesive tape and re-incubated up to day 10 (st36–
37). Embryos were killed by cervical dislocation, a note of their
developmental stage taken and the hind-limbs removed. The limbs
were washed in 0.1 M PBS (pH 7.4) and fixed in 10% NBFS for
1 hour at room temperature before being processed to wax.
Sections were cut (8 mm) and subjected to immunohistochemistry,
protocol previously described, for anti-human collagen-1 (Abcam,
UK) at a dilution of 1:1000 to detect engrafted cells. The antibody
did not cross-react to chick type I collagens or to other chick
collagens. To determine specificity of the antibody, positive
controls were carried out on human cartilage tissue sections and
negative controls were run on non-injected chick limbs.
In situ hybridisation for human-specific Alu genomic repeats: In
situ hybridisation for human Alu genomic repeats was performed
as described previously [4,43].
Caprine in vivo repair study
In order to obtain proof-of principle, a pilot study was carried
out using 6 young, mature female goats. In the first surgical
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procedure a circular 6 mm defect was created in the lateral
femoral condyle whilst preserving the calcified layer. The protocol
followed for cartilage digestion and chondroprogenitor isolation
was identical to that described here for human cartilage
progenitors. Colony forming efficiency and population doublings
for the goat chondroprogenitors were calculated. Cells were
pelleted into a 3D culture system and cultured in chondrogenic
induction media, as described previously in this manuscript.
Immunohistological analysis was performed on goat chondropro-
genitor pellets for Collagen type II (10 mg/ml21; DSHB) and
aggrecan-IGD;6B4 (king gift from Professor Bruce Caterson,
Cardiff University) as described previously. RNA was isolated
from the chondrogenic induced pellet cultures, transcribed to
cDNA and polymerase chain reaction (PCR) performed to
determine Collagen type II and Sox 9 mRNA expression.
Three weeks after the initial isolation, in a second surgical
procedure, 26105 cells were loaded onto a 5 mm diameter type I/
III collagen membrane (Chondro-GideH, Geistlich AG). Three goats
received a membrane with goat chondroprogenitors (mean
population doubling, 21.4) whilst another three goats received a
membrane seeded with full-depth goat chondrocytes (mean
population doubling, 3.5). After debridement of the margins of
the lesion from the previous surgery the membrane was inserted
into the defect and sutured with 8 individual suture points. The
operated limb was immobilised for 2 weeks using a sling. The
animals were sacrificed at 20 months after the second surgery. The
operated knees were dissected, formalin fixed, decalcified and
prepared for routine histology and immunocytochemistry as
described above. Repair tissue grading was performed indepen-
dently, in a blinded manner, by 3 researchers, based on the
International Cartilage Repair Society (ICRS) scoring system.
Results
FACS analysis
Fluorescently activated cell sorting (FACS) analysis was utilised to
label the full-depth chondrocytes for a series of putative cartilage
stem cell markers. Analysis of full-depth chondrocytes for CD105
(endoglin), CD166 (ALCAM), CD44 and CD29 (b1 integrin) all
showed expression in over 95% of the viable cell population
(Fig. 1A–1D). However, expression of CD49e, a5-integrin, was
observed in a distinct population, 0.7%, within the viable full-depth
chondrocyte population (Fig. 1E). On analysis of the clonal
population, isolated using the fibronectin adhesion assay, almost
100% of the cells labelled for CD49e expression (data not shown).
Fibronectin adhesion assay
Fifty percent of the samples showed a CFE (colony forming
efficiency) of less than 0.1 with the remaining 40% demonstrating a
CFE of 0.2 (Fig. 2A). Discrete colonies that form (comprising more
than 32 cells) were selected and cultured in monolayer (Fig. 2C) and
clonal cell proliferative capacity calculated. The cells were able to
proliferate to over 60 population doublings, taking over 200 days
(Fig. 2B). Clones obtained from the same sample proliferated at
similar rates. Differences in growth kinetics were observed between
the clones from different samples. Morphologically, the clonal cell
lines showed a fibroblastic phenotype in early population doubling
monolayer cultures that were retained in long-term cultures. There
were no obvious differences in the size of the cells between early and
late population doublings (Fig. 2D & E).
Monolayer cultures
Monolayer cultures of cartilage progenitors at population
doublings greater than 30 demonstrated positive labelling for stem
cell markers CD90 (Fig. 3A) and STRO-1 (Fig. 3B). Notch 1
receptor and its’ corresponding ligands, Delta 1 and Jagged 1, which
are involved in signalling pathways of stem cell differentiation, were
also expressed in the cartilage progenitor monolayers (Fig. 3C–3E).
Although expression of these putative stem cell markers were
observed in full-depth chondrocytes, it was to a lesser extent
(Fig. 3K, 3L). Analysis of chondrogenic phenotype markers, in
monolayer clonal cell lines post-30 population doublings and
subjected to chondrogenic induction by TGFb2, resulted in the
observed expression of collagen type I, collagen type II, chondroitin-
4-sulphate (2B6), aggrecan-IGD (6B4+) and the chondrogenic
transcription factor, Sox9 (Fig. 3F–3J). The induction of cartilage
gene expression and immuno-detectable matrix synthesis in
monolayer clonal cell lines after 30 population doublings is
significant and noteworthy. Corresponding immunoglobulin con-
trols for the antibodies were all negative (Fig. 3M–3O).
Differentiation assays
At 30 population doublings or greater, clonal cells were
pelleted into 3D Eppendorf cultures and maintained for 21 days
in media containing factors to promote either chondrogenic or
osteogenic differentiation. Four clonal cell lines and a full-depth
chondrocyte sample cultured as pellets in chondrogenic differen-
tiation media, both showed a smooth surface morphology
(Fig. 4A, 4C). Toluidine blue and safranin O staining demon-
strated glycosaminoglycan synthesis 21 days after chondrogenic
culture (Fig. 4B, 4C, 4F, 4G). The presence of collagen fibrils
within the cartilage progenitor pellet matrix was indicated by
picro-sirius red staining (Fig. 4D) and on further analysis,
detection of collagen type I (Fig. 4I) and collagen type II
(Fig. 4J), by immunohistochemical methods, was revealed and
indicated a differentiation process similar to that found during
early development [44]. Positive labelling for aggrecan core
protein, 6B4, was observed intensely in the outer regions of the
pellet with weaker labelling demonstrated in central regions
(Fig. 4K). Labelling for 2B6 was present throughout the pellet
matrix (Fig. 4L). Significantly, neither alkaline phosphatase
(Fig. 4M) nor collagen type X (Fig. 4O) were observed in pellets
cultured in chondrogenic media.
The cartilage progenitor pellets cultured in osteogenic differen-
tiation media showed a rough surface topography and were
slightly smaller in size compared to the full-depth chondrocyte
pellets (Fig. 5A, 5D). When stained for mineralisation, cartilage
progenitor pellets showed extensive regions of calcium deposition
as indicated by both von Kossa (Fig. 5E) and alizarin red stain
(Fig. 5F). The full-depth chondrocyte pellets displayed only small
regions of mineralisation (Fig. 5B). PCR analysis for osteonectin, a
marker for early bone development, demonstrated mRNA
expression in both the full-depth and cartilage progenitor pellets
(Fig. 5M). Osteogenic differentiation was not evident as alkaline
phosphatase activity (Fig. 5G) was seen at a very low level and
collagen type X (Fig. 5I) expression was entirely absent in the
cartilage progenitor pellets.
Clonal cells and full-depth chondrocytes cultured as monolayers
in adipogenic media stained positively for lipid deposition (Fig. 5J,
5K) whereas those cultured in control media did not (Fig. 5L).
PCR analysis for lipo-protein lipase showed mRNA expression in
the full-depth and cartilage progenitor population (Fig. 5M).
Cytogenetic Analysis
Examination of the GTG-banded preparations from 3 flasks
from a clonal cell line from one specimen (54 year old, PD=31.3)
revealed a normal female karyotype, 46, XX (Fig. 5A). However, 2
of 12 cells examined from one of the culture flasks showed a
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terminal deletion of the long arm of chromosome 20, from q11.2
to qter (Fig. 6B). This anomaly was not observed in the other 2
culture flasks. The clonal cell line from the second specimen (10
year old, PD=23.5) showed a normal female 46, XX karyotype in
70 cells examined. However, 10 of the 70 cells examined had an
apparently balanced translocation involving the short arm of
chromosome 7 and the long arm of chromosome 16. The
breakpoints appeared to be at p13 and q22 respectively. The
karyotype from the second clonal cell line (PD=28.5) from the
second specimen showed a normal female karyotype, 46, XX in 50
cells examined from 2 flasks.
Telomere length and telomerase activity analysis
Two clonal cell lines were analysed, one of which is depicted for
greater clarity although data from both were very similar. The
clonal cell line and the full-depth chondrocyte population undergo
telomere erosion with progressive cell divisions (Fig. 6C). It is
interesting to note that the distributions within the clonal cell lines
display less heterogeneity that is normally observed in bulk
populations of cells or tissues where a typical SD of around 3 kb
would be expected. In the clonal cell line, it is apparent that
subsets of cells with a larger distribution are present and the
proportion of cells within this subset is increasing with time in
Figure 1. Flow cytometric analysis of full-depth chondrocytes. Full-depth chondrocytes were labelled for the putative stem cell surface
markers CD105 (A), CD166 (B), CD44 (C), CD29 (D) and CD49e (E). Note the subpopulation of cells labelled for CD49e. Corresponding immunoglobulin
control samples were analysed for each marker at each experimental run (F–I).
doi:10.1371/journal.pone.0013246.g001
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culture (Fig. 6C, arrowed). Full-depth chondrocytes displayed
almost baseline levels of telomerase activity in both low (PD12)
and high (PD49) population doubling cultures (Fig. 6D). The
clonal cell line at a high population doubling (PD39) exhibited the
greatest telomerase activity, even higher than that of the low
population doubling (PD26) clonal cell line, possibly due to the
presence of a subset of cells showing a high telomere length. When
converted to HL60 cell equivalent units, the clonal cell line showed
Figure 2. Population data from clonal cell lines. Colony forming efficiency calculated from 8 samples that were subjected to the fibronectin
adhesion assay (as described in Materials & Methods) (A). Population doublings data from 2 representative samples demonstrating proliferative rate
of the clonal cell lines during a period of over 200 days (B). Phase contrast microscopic appearance of a representative fibronectin adhered colony (C)
and clonal monolayers at low (,30) and high (.30) population doublings (D & E respectively). Scale bar = 100 mm.
doi:10.1371/journal.pone.0013246.g002
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3.1-fold greater telomerase activity than full-depth chondrocytes at
low population doubling and at the high population doubling this
figure increased to a 10.3-fold difference.
Engraftment of cartilage progenitor cell lines
In order to test for in vivo plasticity, cartilage progenitor cells
were injected into st23 chick hind limbs. A high number of cells
Figure 3. Phenotype of cartilage progenitor and full-depth chondrocyte cell lines. Monolayer cultures of expanded clonal cell lines at over
30 population doublings express the putative stem cell markers, CD90 (A) and STRO-1 (B) when localised using immunofluorescent labelling (green).
Members of the Notch signalling family, Notch 1 (C), Delta 1 (D) and Jagged 1 (E) were expressed in clonal monolayer cultures. Markers of the
chondrogenic phenotype, collagen type II (G), 2B6 (H), aggrecan-IGD (I), Sox9 (J), and also, collagen type I (F) were present in clonal monolayer
cultures at over 30 population doublings. Full-depth chondrocytes show fewer cells with positive expression of CD90 (K) and Notch 1 (L) within the
monolayer cultures. Corresponding immunoglobulin controls, rabbit (M), goat (N) and mouse (O), were all negative. Scale bars = 50 mm.
doi:10.1371/journal.pone.0013246.g003
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labelling positively for human collagen type I were observed in the
perichondrium and alongside the prehypertrophic region of the
developing anlagen (Fig. 7A, 7B). Controls determined that the
human collagen type I antibody was specific for human collagen
type I and did not recognise chick collagen type I or other chick
collagens (Fig. 7D, 7E). In situ hybridisation for human Alu repeats,
on a representative section from a chick limb 7 days after human
clonal cell transplantation showed human Alu-positive nuclei
stained black in the peri-articular tissues (Fig. 7C). Control sections
were negative (Fig. 7F).
Caprine in vivo repair study
In order to determine whether articular cartilage progenitors
are suitable candidates for cartilage repair, we carried out a proof
of principle pilot study on goats. Chondroprogenitors obtained
from the goat study demonstrated an average CFE of 0.2. Positive
collagen type II and aggrecan labelling was observed by both
immunohistological and PCR analysis in the 3D chondrogenic
pellet cultures.
The ICRS scoring system designed by Brittberg and Peterson
[45] was used to evaluate cartilage repair in the goat tissue
sections. Histological repair scores for full-depth chondrocytes
ranged from 5 (abnormal) to 10 (nearly normal) whilst repair
scores for chondroprogenitors ranged from 7 (abnormal) to 10
(nearly normal). Overall, full-depth chondrocytes had a mean
score of 7.8 and chondroprogenitors had a mean score of 8.2 thus
suggesting no overall differences between the two experimental
groups. Examples of excellent lateral integration in both full-depth
chondrocyte (Fig. 7G, 7I) and chondroprogenitor (Fig. 7H, 7J)
treatment groups were observed. In some of the samples, there was
no obvious demarcating border and it was difficult to tell where
the defect actually was. In all of the samples, both full-depth
chondrocyte (Fig. 7K) and chondroprogenitor seeded membranes
(Fig. 7L) showed evidence of collagen type II positive repair tissue.
Discussion
Previous research has relied on cell surface markers, originally
designated to characterise bone marrow stromal cells, as a means
of isolating possible stem cell populations from articular cartilage
[27,29,46]. In particular, research suggested that CD105 and
CD166 as possible candidates of cartilage stem cell markers but
our study and others have demonstrated that a sub-population of
cartilage stem cells cannot be isolated from these markers alone as
Figure 4. Chondrogenic differentiation of cartilage progenitor and full-depth chondrocyte populations. Gross morphology of a representative
3D cartilage progenitor (A) and full depth chondrocyte (B) pellet cultured in chondrogenic media for 21 days. Pellets display a shiny smooth surface. Toluidine
blue (B, F) and safranin O (C, G) stained pellets demonstrate the presence of glycosminoglycans within the pellet matrix. Picro-sirius red staining highlights
synthesis of collagen fibres in the pellet matrix (D, H). Immunohistochemistry of the clonal pellets demonstrates both collagen type I (I) and collagen type II (J)
within the chondrogenic pellet matrix. Aggrecan labelling was present on the outer edge of the chondrogenic pellet (K) and 2B6 expression was present
throughout the pellet matrix (L). Pellets cultured in chondrogenic media show no alkaline phosphatase (M) or collagen type X expression (N). Representative
examples of negative controls for mouse monoclonal (O) and rabbit polyclonal (P) antibody protocols. Scale bars = 50 mm.
doi:10.1371/journal.pone.0013246.g004
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Figure 5. Lineage differentiation of clonal and full depth cell populations. Pellets cultured in osteogenic differentiation media show a
rough surface topography in the full depth chondrocytes (A) and in cartilage progenitor cell pellets (D). Regions of mineralisation are indicated in the
pellets cultured in osteogenic media by von Kossa (B, E) and alizarin red staining (C, F). Alkaline phosphatase (G;arrowed) was present in a small
region of the osteogenic cartilage progenitor cultured pellets and collagen type X was absent (I). Representative example of a negative control for
mouse monoclonal antibody protocol (H). Monolayer clonal cells cultured in adipogenic differentiation media show positive staining with Oil Red O
in both cartilage progenitor cells (J) and full depth chondrocytes (K). Control cultures did not stain with Oil Red O (L). Scale bars = 50 mm. mRNA
expression for lipo-protein lipase (bp 505) and osteonectin (bp 107) in non-treated monolayer (ML) chondrocytes, treated full-depth chondrocytes
(FD) and treated cartilage progenitors (CP) (M).
doi:10.1371/journal.pone.0013246.g005
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Figure 6. Cytogenetic Analysis. Normal female, 46, XX karyotype was observed in a clonal cell line at 31.3 population doublings (A). In one flask
from the same cell line, 2 out of 12 cells displayed an abnormal karyotype; a deletion on the long arm of chromosome 20 at q11.2 (B; arrowed).
Telomere length analysis and real-time quantitative telomere repeat amplification procedure (RTQ-TRAP) of telomerase activity in
clonal cell lines and full-depth chondrocyte populations. STELA reveals both clonal cell lines and full-depth chondrocytes undergo telomere
erosion (C). It is interesting to note a subpopulation of cells in the clonal cell line show a larger distribution which is increasing with time in culture
(arrowed). RTQ-TRAP analyses of telomerase activity in HL60 cell equivalents showed low population doubling (,30) clonal cells displaying a 3.1-fold
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they are widely expressed by mature chondrocytes in the native
tissue [29,30,47]. Isolating a possible stem cell population reliant
on stem cell marker expression, however, could prove problematic
for cell-based repair therapies. In a clinical situation, isolation of
the correct cell population in suitable numbers would be
dependent on an extremely consistent method of cartilage
digestion and culture conditions, as these parameters play a
significant role in cell surface marker expression. Indeed, work
from our own laboratory and others have demonstrated that these
putative markers vary during culture [48]. Additionally, clinically
accredited FACs machines have yet to come on-stream.
In light of these studies, we decided to isolate what we now
characterise as a cartilage progenitor population using the
fibronectin adhesion assay, selecting for discrete colonies (of over
32 cells to eliminate transit amplifiers) which could then be
expanded to high numbers [33]. Currently, generation of high
numbers of chondrogenically competent full-depth chondrocytes
for cell-based repair strategies is not achievable due to the loss of
Sox-9 expression and concomitant loss of the cartilage phenotype
[26,49]. Expansion of our cartilage progenitor clonal populations
to a high population doubling suggests that this method of isolation
is indeed selecting for cartilage progenitor populations.
It is interesting to observe that a sub-population (0.7%) of cells
within the total chondrocyte cell mass express CD49e (a5 integrin)
and indeed the clonal cell lines obtained by adhesion to fibronectin
express this marker (99%) when expanded. The expression of this
marker may explain the high affinity of these progenitor cells for
fibronectin. Whether or not CD49e can be utilised as a specific
marker for this cartilage progenitor cell population remains to be
determined. However, the colony forming efficiency of these cells
indicates that they are present at a ratio of 1:100, which is in the
order of 0.7%.
The cytogenetic analyses demonstrated that cartilage progen-
itors that had undergone 31.3 population doublings are largely
normal but with some anomalies that are likely due to the high PD
number and culture conditions. This was particularly apparent in
the deletion of the short arm of chromosome 20 in one flask yet
not apparent in the other two flasks containing the same clonal cell
line. It can be considered cautionary and underlies the necessity of
carrying out a karyotype analysis when generating cells for clinical
application.
It is well documented that when full depth chondrocytes in
monolayer culture lose their rounded cell configuration, there is a
loss of phenotype associated with the number of division cycles the
cell undergoes and the eventual loss of Sox9 expression
[5,50,51,52,53]. Monolayer cartilage progenitor populations that
have been isolated in this study, although demonstrating a
flattened morphology in culture, show expression of putative stem
cell markers, yet when induced to undergo chondrogenic
differentiation by addition of TGFb2, markers of the chondro-
genic phenotype are expressed and translated into immuno-
detectable proteins. Using the bovine equivalent progenitor cells,
we have demonstrated that the extended chondrogenic potential of
these cells is related to the maintenance of Sox9 expression during
extended monolayer culture and we would suggest that this is
likely with the human equivalent cells [26].
Another effect of long-term chondrocyte culture is cell
senescence due to a shortening of telomeres, the DNA sequences
necessary for chromosome replication [54,55,56]. As true stem
cells maintain their telomere length and show unlimited replicative
capacity, this provided a way of characterising the isolated
cartilage progenitor population and also strengthened the case
for their suitability for cell-based repair therapies [57]. Full-depth
chondrocytes and cartilage progenitors investigated in our study
displayed eroded telomeres with time in culture consistent with
growth kinetic data. However, if we study the results in more
detail, a sub-population of cells within the cartilage progenitor
population is observed that maintain their telomere length.
Indeed, this sub-population of cells maintains their telomere
length and increases in number with time in culture. However, we
do not find this sub-population expanding beyond 60 PDs and
may senesce in a telomere independent fashion.
The cartilage progenitor population express a number of
chondrogenic markers and matrix components when induced to
undergo chondrogenesis in vitro, including collagen type I and
collagen type II. In culture, collagen type I is often considered an
indicator of fibrocartilage. However, the expression of collagen type
II in the chondrogenic cell pellets suggests that the cartilage
progenitors are following a developmental process in their matrix
synthesis, synthesising firstly collagen type I and secondly collagen
type II as the cells mature [44]. Evidence of co-localisation of the
two collagens at the articular surfaces was described in a study by
Archer et al [58] and it is interesting to note that collagen type 1 is
observed in the pellets in the outer layer of cells, which appear
flattened – similar to the flattened interzone cells and perichondri-
um in the developing limb, as described in the same study.
Osteogenically induced cultures show signs of mineralisation when
cultured as a 3D pellet. However, there is no evidence of bone
formation per se; neither collagen type X protein expression nor
alkaline phosphatase activity were evident in the chondrogenic or
osteogenically induced 3D cultured pellets. These data highlight
that cartilage progenitors neither undergo chondrogenic terminal
differentiation nor true osteogenesis. Notably, many published
studies assay osteogenesis of stem cells in monolayer culture through
analysis of expression of alkaline phosphatase and the appearance of
calcification by von Kossa staining that de facto, is not an assay for
bone formation. Indeed, if the cells are demonstrating a restricted
differentiation potential in vitro, then the ability of these cells to form
stable ectopic cartilage that doesn’t undergo terminal differentiation
in vivo would be a very desirable factor for using these cells in clinical
applications for cartilage repair strategies. In contrast, current
research into BMSCs for cartilage regeneration procedures
demonstrates terminal differentiation and extracellular matrix
(ECM) calcification in vitro upon chondrogenic induction, ultimately
resulting in failure of transplantation [16,22,59,60].
Multi-lineage potential is often used to characterise a
mesenchymal stem cell population. The results from our study
demonstrate that the cartilage progenitor cells have the capacity
to differentiate into the adipogenic lineage, whilst retaining a
restricted differentiation potential during osteogenic differentia-
tion, as discussed above. However, the full-depth chondrocytes
are also positive for differentiation into these lineages, albeit to a
lesser extent. This can be explained as such; during the isolation
procedure, progenitor cells are part of the full-depth chondrocyte
culture and are likely to have become enriched during the cell
expansion process. This small progenitor population within the
full-depth chondrocytes would, therefore, undergo differentia-
tion when cultured in the appropriate media, as we have
observed.
greater activity than low population full depth chondrocytes (D). High population doubling clonal cells show a 10.6-fold greater activity than full
depth chondrocytes at a high population doubling (.30). PD = population doubling.
doi:10.1371/journal.pone.0013246.g006
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Characteristically, mesenchymal stem cells can migrate and
engraft into tissues, including regions of injury, and undergo site-
specific differentiation [61,62,63]. It is encouraging to see that data
from our engraftment studies demonstrated that the cartilage
progenitor population can migrate to its specific milieu within the
developing limb. The isolated cartilage progenitor populations
largely engrafted within the perichondrium – an already known
niche of stem cells and the cells also migrated to the surface of the
articular cartilage – where data by Dowthwaite et al [25] has
demonstrated the presence of a progenitor population. However,
engrafted cells were observed in other connective tissues including
dermis but were not seen outside tissues of the connective tissue
lineage, lending further support to progenitor status.
To determine the potential of chondroprogenitors in in vivo
cartilage repair, we have used the goat as our model. The goat
chondroprogenitors were isolated and characterised in the same
manner as the human chondroprogenitors. The caprine in vivo
repair study revealed examples of excellent integration in cartilage
defects treated with Chondro-GideH membrane seeded with goat
chondroprogenitors. When subjected to the ICRS scoring system
to evaluate cartilage repair, however, there was no difference in
repair between defects that were treated with chondroprogenitors
and those treated with the current gold standard of expanded full-
depth chondrocytes. Although, no differences in repair tissue were
observed at the 20-month end point of the study, the main
advantage of these cells over full-depth chondrocytes is the ability
to generate very large cell numbers that retain their phenotype,
from a single cell. As a result, it would be feasible to treat much
larger defects than is currently possible.
Conclusion
The main findings from these data lead to the conclusion that
human articular cartilage contains a cartilage progenitor population
that retains a stem cell-like phenotype until appropriate induction of
chondrogenic differentiation is required. As such, we propose that
this cell population is an ideal candidate to use in the development
of enhanced protocols for future cell-based tissue engineering
procedures that require cells with an extensive replication capacity
and restricted differentiation potential. As a single cell can generate
millions of cells that retain their chondrogenic phenotype in vivo, this
isolation procedure would ensure sufficient numbers of cells, that
maintain their ability to form cartilage, are readily available for
surgical procedures. These characteristics are favourable if the
transplanted cells are to physically contribute to the repair and
maintenance of the cartilage defect long-term.
Supporting Information
Text S1 Immunohistochemistry.
Found at: doi:10.1371/journal.pone.0013246.s001 (0.04 MB
DOC)
Text S2 Cytogenetic Analysis.
Found at: doi:10.1371/journal.pone.0013246.s002 (0.04 MB
DOC)
Text S3 Telomere length analysis.
Found at: doi:10.1371/journal.pone.0013246.s003 (0.04 MB
DOC)
Text S4 RTQ-TRAP.
Found at: doi:10.1371/journal.pone.0013246.s004 (0.04 MB
DOC)
Author Contributions
Conceived and designed the experiments: RW IMK HEM CWA.
Performed the experiments: RW IMK KR LN HEM TA SKS REJ
DMB HL SR GPD. Analyzed the data: RW IMK KR HEM SKS DMB
HL SR HMS CWA. Contributed reagents/materials/analysis tools: RW
DMB SR JD JF TB CWA. Wrote the paper: RW IMK HEM SKS DMB
SR CWA.
References
1. Khan IM, Redman SN, Williams R, Dowthwaite GP, Oldfield SF, et al. (2007)
The development of synovial joints. Curr Top Dev Biol 79: 1–36.
2. Cournil-Henrionnet C, Huselstein C, Wang Y, Galois L, Mainard D, et al.
(2008) Phenotypic analysis of cell surface markers and gene expression of human
mesenchymal stem cells and chondrocytes during monolayer expansion.
Biorheology 45: 513–526.
3. Schnabel M, Marlovits S, Eckhoff G, Fichtel I, Gotzen L, et al. (2002)
Dedifferentiation-associated changes inmorphology and gene expression in primary
human articular chondrocytes in cell culture. Osteoarthritis Cartilage 10: 62–70.
4. Dell’Accio F, De Bari C, Luyten FP (2001) Molecular markers predictive of the
capacity of expanded human articular chondrocytes to form stable cartilage in
vivo. Arthritis Rheum 44: 1608–1619.
5. Benya PD, Shaffer JD (1982) Dedifferentiated chondrocytes reexpress the
differentiated collagen phenotype when cultured in agarose gels. Cell 30:
215–224.
6. Jakob M, Demarteau O, Schafer D, Hintermann B, Dick W, et al. (2001)
Specific growth factors during the expansion and redifferentiation of adult
human articular chondrocytes enhance chondrogenesis and cartilaginous tissue
formation in vitro. J Cell Biochem 81: 368–377.
7. Li Y, Tew SR, Russell AM, Gonzalez KR, Hardingham TE, et al. (2004)
Transduction of passaged human articular chondrocytes with adenoviral,
retroviral, and lentiviral vectors and the effects of enhanced expression of
SOX9. Tissue Eng 10: 575–584.
8. Wolf F, Candrian C, Wendt D, Farhadi J, Heberer M, et al. (2008) Cartilage
tissue engineering using pre-aggregated human articular chondrocytes. Eur Cell
Mater 16: 92–99.
9. Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E, et al. (2000)
Two- to 9-year outcome after autologous chondrocyte transplantation of the
knee. Clin Orthop Relat Res. pp 212–234.
10. Tuli R, Li WJ, Tuan RS (2003) Current state of cartilage tissue engineering.
Arthritis Res Ther 5: 235–238.
11. Roberts S, McCall IW, Darby AJ, Menage J, Evans H, et al. (2003)
Autologous chondrocyte implantation for cartilage repair: monitoring its
success by magnetic resonance imaging and histology. Arthritis Res Ther 5:
R60–73.
12. Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review:
mesenchymal stem cells: their phenotype, differentiation capacity, immunolog-
ical features, and potential for homing. Stem Cells 25: 2739–2749.
Figure 7. Engraftment of human cartilage progenitor cells into developing chick hind limbs. Cells expressing human collagen type I are
present in the growth plate of the developing chick limb at st36 (A). The high power image demonstrates human collagen type I expression in the
surface region of the developing cartilage anlagen (B). IgG negative control (D). Expression of chick collagen type I is not evident in st36 chick limb
(E). ISH for human Alu repeats on a representative section from a st36 chick limb (C). The Alu-positive nuclei are stained black (arrowed). Negative
control for ISH for the Alu repeats (F). Scale bars = 50 mm. In vivo implantation of goat chondroprogenitors into cartilage defects.
Histological stained sections of repair tissue in the caprine in vivo repair model. Toluidine blue stained sections of repair tissue containing the
membrane seeded with full-depth chondrocytes (G) and chondroprogenitors (H) shows examples of an integrated repair tissue. Safranin O staining
demonstrated proteoglycan synthesis in the repair tissue in defects treated with full-depth chondrocyte seeded membranes (I) and
chondroprogenitor seeded membranes (J). Repair tissue in defects treated with chondrocyte seeded membranes (K) or chondroprogenitor seeded
membranes (L), labelled positive for collagen type II. Scale bars = 100 mm.
doi:10.1371/journal.pone.0013246.g007
Cartilage Progenitor Cells
PLoS ONE | www.plosone.org 13 October 2010 | Volume 5 | Issue 10 | e13246
13. Yang X, Zhang W, van den Dolder J, Walboomers XF, Bian Z, et al. (2007)
Multilineage potential of STRO-1+ rat dental pulp cells in vitro. J Tissue Eng
Regen Med 1: 128–135.
14. Lee RH, Kim B, Choi I, Kim H, Choi HS, et al. (2004) Characterization and
expression analysis of mesenchymal stem cells from human bone marrow and
adipose tissue. Cell Physiol Biochem 14: 311–324.
15. Waddington RJ, Youde SJ, Lee CP, Sloan AJ (2009) Isolation of distinct
progenitor stem cell populations from dental pulp. Cells Tissues Organs 189:
268–274.
16. Mareddy S, Crawford R, Brooke G, Xiao Y (2007) Clonal isolation and
characterization of bone marrow stromal cells from patients with osteoarthritis.
Tissue Eng 13: 819–829.
17. Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, Flores-Guzman P,
Hernandez-Estevez E, et al. (2009) Human mesenchymal stromal cells from
adult and neonatal sources: comparative analysis of their morphology,
immunophenotype, differentiation patterns and neural protein expression.
Cytotherapy 11: 163–176.
18. Vidal MA, Robinson SO, Lopez MJ, Paulsen DB, Borkhsenious O, et al. (2008)
Comparison of chondrogenic potential in equine mesenchymal stromal cells
derived from adipose tissue and bone marrow. Vet Surg 37: 713–724.
19. Rada T, Reis RL, Gomes ME (2009) Adipose Tissue-Derived Stem Cells and
Their Application in Bone and Cartilage Tissue Engineering. Tissue Eng
Part B Rev.
20. Seda Tigli R, Ghosh S, Laha MM, Shevde NK, Daheron L, et al. (2009)
Comparative chondrogenesis of human cell sources in 3D scaffolds. J Tissue Eng
Regen Med.
21. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU (1998) In vitro
chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell
Res 238: 265–272.
22. Murdoch AD, Grady LM, Ablett MP, Katopodi T, Meadows RS, et al. (2007)
Chondrogenic differentiation of human bone marrow stem cells in transwell
cultures: generation of scaffold-free cartilage. Stem Cells 25: 2786–2796.
23. Connelly JT, Wilson CG, Levenston ME (2008) Characterization of proteogly-
can production and processing by chondrocytes and BMSCs in tissue engineered
constructs. Osteoarthritis Cartilage 16: 1092–1100.
24. Hayes AJ, MacPherson S, Morrison H, Dowthwaite G, Archer CW (2001) The
development of articular cartilage: evidence for an appositional growth
mechanism. Anat Embryol (Berl) 203: 469–479.
25. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, et al. (2004) The
surface of articular cartilage contains a progenitor cell population. J Cell Sci 117:
889–897.
26. Khan IM, Bishop JC, Gilbert S, Archer CW (2009) Clonal chondroprogenitors
maintain telomerase activity and Sox9 expression during extended monolayer
culture and retain chondrogenic potential. Osteoarthritis Cartilage 17: 518–528.
27. Grogan SP, Barbero A, Diaz-Romero J, Cleton-Jansen AM, Soeder S, et al.
(2007) Identification of markers to characterize and sort human articular
chondrocytes with enhanced in vitro chondrogenic capacity. Arthritis Rheum
56: 586–595.
28. Hiraoka K, Grogan S, Olee T, Lotz M (2006) Mesenchymal progenitor cells in
adult human articular cartilage. Biorheology 43: 447–454.
29. Alsalameh S, Amin R, Gemba T, Lotz M (2004) Identification of mesenchymal
progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis
Rheum 50: 1522–1532.
30. de la Fuente R, Abad JL, Garcia-Castro J, Fernandez-Miguel G, Petriz J, et al.
(2004) Dedifferentiated adult articular chondrocytes: a population of human
multipotent primitive cells. Exp Cell Res 297: 313–328.
31. Diaz-Romero J, Nesic D, Grogan S, Heini P, Mainil-Varlet P (2008)
Immunophenotypic changes of human articular chondrocytes during monolayer
culture reflect bona fide dedifferentiation rather than amplification of progenitor
cells. Journal of Cellular Physiology 214: 75–83.
32. Karlsson C, Stenhamre H, Sandstedt J, Lindahl A (2008) Neither Notch1
expression nor cellular size correlate with mesenchymal stem cell properties of
adult articular chondrocytes. Cells Tissues Organs 4: 275–285.
33. Jones PH, Watt FM (1993) Separation of human epidermal stem cells from
transit amplifying cells on the basis of differences in integrin function and
expression. Cell 73: 713–724.
34. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC (1998) Relationship
between donor age and the replicative lifespan of human cells in culture: a
reevaluation. Proc Natl Acad Sci U S A 95: 10614–10619.
35. Barbero A, Grogan S, Schafer D, Heberer M, Mainil-Varlet P, et al. (2004) Age
related changes in human articular chondrocyte yield, proliferation and post-
expansion chondrogenic capacity. Osteoarthritis Cartilage 12: 476–484.
36. Yang R, Davies CM, Archer CW, Richards RG (2003) Immunohistochemistry
of matrix markers in Technovit 9100 New-embedded undecalcified bone
sections. Eur Cell Mater 6: 57–71; discussion 71.
37. Singhrao S, Mu¨ller C, Gilbert S, Duance V, Archer C (2009) An
immunofluorescence method for post-embedded tissue in acrylic resin
Technovit 9100 NewH using fluorescein isothiocyanate secondary detection
marker. Microsc Res Tech Online; ahead of press.
38. Boyle T, Griffin D (2001) The cytogenetics of pregnancy. In: Rooney D, ed.
Human Cytogenetics:constitutional analysis. 3rd ed:. Oxford: Oxford University
Press. pp 55–98.
39. Shaffer L, Tommerup N (2005) An International System fro Human
Cytogenetic Nomenclature. In: Karger S, ed. Basel.
40. Seabright M (1972) The use of proteolytic enzymes for the mapping of structural
rearrangements in the chromosomes of man. Chromosoma 36: 204–210.
41. Capper R, Britt-Compton B, Tankimanova M, Rowson J, Letsolo B, et al.
(2007) The nature of telomere fusion and a definition of the critical telomere
length in human cells. Genes Dev 21: 2495–2508.
42. Hamburger V, Hamilton HL (1951) A series of normal stages in the
development of the chick embryo. J Morphology 88: 49–92.
43. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, et al. (1997)
Single-colony derived strains of human marrow stromal fibroblasts form bone
after transplantation in vivo. J Bone Miner Res 12: 1335–1347.
44. Craig FM, Bentley G, Archer CW (1987) The spatial and temporal pattern of
collagens I and II and keratan sulphate in the developing chick metatarsopha-
langeal joint. Development 99: 383–391.
45. Brittberg M, Peterson L (1998) Introduction of an articular cartilage
classification. ICRS Newsletter 1.
46. Grogan SP, Miyaki S, Asahara H, D’Lima DD, Lotz MK (2009) Mesenchymal
progenitor cell markers in human articular cartilage: normal distribution and
changes in osteoarthritis. Arthritis Res Ther 11: R85.
47. Diaz-Romero J, Nesic D, Grogan SP, Heini P, Mainil-Varlet P (2008)
Immunophenotypic changes of human articular chondrocytes during monolayer
culture reflect bona fide dedifferentiation rather than amplification of progenitor
cells. J Cell Physiol 214: 75–83.
48. Diaz-Romero J, Gaillard JP, Grogan SP, Nesic D, Trub T, et al. (2005)
Immunophenotypic analysis of human articular chondrocytes: changes in
surface markers associated with cell expansion in monolayer culture. J Cell
Physiol 202: 731–742.
49. Kolettas E, Buluwela L, Bayliss MT, Muir HI (1995) Expression of cartilage-
specific molecules is retained on long-term culture of human articular
chondrocytes. J Cell Sci 108(Pt 5): 1991–1999.
50. Glowacki J, Trepman E, Folkman J (1983) Cell shape and phenotypic expression
in chondrocytes. Proc Soc Exp Biol Med 172: 93–98.
51. von der Mark K, Gauss V, von der Mark H, Muller P (1977) Relationship
between cell shape and type of collagen synthesised as chondrocytes lose their
cartilage phenotype in culture. Nature 267: 531–532.
52. Watt FM, Dudhia J (1988) Prolonged expression of differentiated phenotype by
chondrocytes cultured at low density on a composite substrate of collagen and
agarose that restricts cell spreading. Differentiation 38: 140–147.
53. Archer CW, Rooney P, Wolpert L (1982) Cell shape and cartilage differentiation
of early chick limb bud cells in culture. Cell Differ 11: 245–251.
54. Martin JA, Mitchell CJ, Klingelhutz AJ, Buckwalter JA (2002) Effects of
telomerase and viral oncogene expression on the in vitro growth of human
chondrocytes. J Gerontol A Biol Sci Med Sci 57: B48–53.
55. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569–573.
56. Martin JA, Buckwalter JA (2001) Telomere erosion and senescence in human
articular cartilage chondrocytes. J Gerontol A Biol Sci Med Sci 56: B172–179.
57. Allen ND, Baird DM (2009) Telomere length maintenance in stem cell
populations. Biochim Biophys Acta 1792: 324–328.
58. Archer CW, Morrison H, Pitsillides AA (1994) Cellular aspects of the
development of diarthrodial joints and articular cartilage. J Anat 184(Pt 3):
447–456.
59. Ichinose S, Tagami M, Muneta T, Sekiya I (2005) Morphological examination
during in vitro cartilage formation by human mesenchymal stem cells. Cell
Tissue Res 322: 217–226.
60. Pelttari K, Winter A, Steck E, Goetzke K, Hennig T, et al. (2006) Premature
induction of hypertrophy during in vitro chondrogenesis of human mesenchymal
stem cells correlates with calcification and vascular invasion after ectopic
transplantation in SCID mice. Arthritis Rheum 54: 3254–3266.
61. Koelling S, Kruegel J, Irmer M, Path JR, Sadowski B, et al. (2009) Migratory
chondrogenic progenitor cells from repair tissue during the later stages of human
osteoarthritis. Cell Stem Cell 4: 324–335.
62. Rooney G, McMahon S, Ritter T, Garcia Y, Moran CJ, et al. (2009)
Neurotrophic Factor-Expressing Mesenchymal Stem Cells Survive Transplan-
tation into the Contused Spinal Cord without Differentiating into Neural Cells.
Tissue Eng Part A Mar 31, Epub ahead of print.
63. Tuan RS (2007) A second-generation autologous chondrocyte implantation
approach to the treatment of focal articular cartilage defects. Arthritis Res Ther
9: 109.
Cartilage Progenitor Cells
PLoS ONE | www.plosone.org 14 October 2010 | Volume 5 | Issue 10 | e13246
